why choose us

First received: May 29, 2023

Clinical Trial: Evaluate the Safety and Tolerability of SCT650C in Healthy Volunteers

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Autoimmune Disease

Study Type: INTERVENTIONAL


Official Title: A Randomized, Double-blinded, Dose-escalation Phase Ia Study to Evaluate the Safety and Tolerability of SCT650C in Healthy Volunteers

Brief Summary: The goal of clinical trial is to evaluate the safety and tolerability of SCT650C in healthy participants.

Read more